Literature DB >> 33405414

How to diagnose delayed cerebral ischaemia and symptomatic vasospasm and prevent cerebral infarction in patients with subarachnoid haemorrhage.

Verena Rass1, Raimund Helbok.   

Abstract

PURPOSE OF REVIEW: Delayed cerebral ischaemia (DCI) complicates the clinical course of patients with subarachnoid haemorrhage (SAH) in 20--30% and substantially worsens outcome. In this review, we describe a multimodal diagnostic approach based on underlying mechanisms of DCI and provide treatment options with a special focus on the most recently published literature. RECENT
FINDINGS: Symptomatic vasospasm refers to clinical deterioration in the presence of vasospasm whereas DCI constitutes multiple causes. Pathophysiologic mechanisms underlying DCI range beyond large vessel vasospasm from neuroinflammation, to microthromboembolism, impaired cerebral autoregulation, cortical spreading depolarizations and many others. The current definition of DCI can be challenged by these mechanisms. We propose a pragmatic approach using a combination of clinical examination, cerebral ultrasonography, neuroimaging modalities and multimodal neuromonitoring to trigger therapeutic interventions in the presence of DCI. In addition to prophylactic nimodipine and management principles to improve oxygen delivery and decrease the brain metabolic demand, other specific interventions include permissive hypertension, intra-arterial application of calcium channel blockers and in selected patients angioplasty.
SUMMARY: The complex pathophysiology underlying DCI urges for a multimodal diagnostic approach triggering targeted interventions. Novel treatment concepts still have to be proven in large trials.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33405414     DOI: 10.1097/MCC.0000000000000798

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  8 in total

Review 1.  MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases.

Authors:  Mohammad Reza Kalhori; Masoud Soleimani; Kheirollah Yari; Mahmoudreza Moradi; Amir Ali Kalhori
Journal:  Clin Exp Med       Date:  2022-07-08       Impact factor: 3.984

Review 2.  Cortical Spreading Depolarizations in Aneurysmal Subarachnoid Hemorrhage: An Overview of Current Knowledge and Future Perspectives.

Authors:  Moncef Berhouma; Omer Faruk Eker; Frederic Dailler; Sylvain Rheims; Baptiste Balanca
Journal:  Adv Tech Stand Neurosurg       Date:  2022

3.  Multimodal monitoring to guide neurosurgical intervention in high-grade aneurysmal subarachnoid hemorrhage: illustrative case.

Authors:  Bradley Kolb; Daniel Wolfson; Ivan Da Silva; Stephan A Munich
Journal:  J Neurosurg Case Lessons       Date:  2022-06-27

4.  Classification Algorithm-Based fMRI Images for Evaluating the Effect of Yishen Tiaodu Acupuncture on the Recovery Period of Cerebral Infarction.

Authors:  Zhuo Feng; Miaomiao Hu; Wei Yuan; Xiaojun Zhao; Jiazhi Zeng; Kaibin Zhou
Journal:  Comput Intell Neurosci       Date:  2022-05-25

5.  Cerebral Microdialysis-Based Interventions Targeting Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Jakob Winberg; Isabella Holm; David Cederberg; Malin Rundgren; Erik Kronvall; Niklas Marklund
Journal:  Neurocrit Care       Date:  2022-04-29       Impact factor: 3.532

6.  Longitudinal ventricular cerebrospinal fluid profile in patients with spontaneous subarachnoid hemorrhage.

Authors:  Anne Zinganell; Gabriel Bsteh; Franziska Di Pauli; Verena Rass; Raimund Helbok; Janette Walde; Florian Deisenhammer; Harald Hegen
Journal:  Front Neurol       Date:  2022-07-26       Impact factor: 4.086

7.  Hyperoxia is Dose-Dependently Associated with an Increase of Unfavorable Outcomes in Ventilated Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cohort Study.

Authors:  Jörn Grensemann; Marius Marc-Daniel Mader; Manfred Westphal; Stefan Kluge; Patrick Czorlich
Journal:  Neurocrit Care       Date:  2022-06-08       Impact factor: 3.532

Review 8.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.